Related Experiment Videos
[The symptomatic patient with pathologic coronary angiogram. "evidence-based" or "best-evidence medicine" in the
Insights
Ischemic heart disease (IHD) remains a leading cause of death. This review examines evidence-based strategies, including conservative, percutaneous, and surgical options, to optimize treatment for patients with symptomatic coronary artery disease.
Area of Science:
- Cardiology
- Public Health
Background:
- Ischemic heart disease (IHD) is a primary cause of mortality in industrialized nations, driven by risk factors and an aging demographic.
- Advancements in conservative, surgical, and interventional treatments have reduced IHD morbidity and mortality but escalated healthcare expenses.
- This necessitates a discussion on the optimal application of therapeutic measures, guided by evidence-based medicine.
Purpose of the Study:
- To review recent clinical trials on managing symptomatic coronary artery disease.
- To discuss the optimal therapeutic strategy (conservative, percutaneous, or surgical revascularization) for different patient profiles.
Main Methods:
- Systematic review of recently published clinical trials.
- Analysis of evidence-based medicine principles.
- Comparative discussion of therapeutic interventions.
Main Results:
- Evidence suggests varying efficacy and cost-effectiveness of different revascularization strategies.
- Patient-specific factors significantly influence the choice of optimal treatment.
- Optimal strategy selection requires careful consideration of clinical presentation and evidence.
Conclusions:
- The optimal management of symptomatic coronary artery disease involves selecting between conservative care, percutaneous coronary intervention, or coronary artery bypass grafting.
- Personalized treatment decisions based on clinical trial evidence are crucial for improving outcomes and managing costs.
- Further research is needed to refine treatment guidelines for diverse patient populations.
Abstract:
Ischemic heart disease is the most frequent cause of death in industrialized countries. This is a result of persistent risk factors and aging of the population. Medical progress with application of conservative, surgical or interventional strategies indeed reduced the morbidity and mortality of arteriosclerotic diseases, but markedly increased the medical care costs. The result is a discussion about the optimal use of the different therapeutic measures under consideration of the evidence based medicine. This article reviews several recently published clinical trials and discusses, which patient with symptomatic coronary artery disease should undergo a conservative strategy, percutaneous or surgical revascularization.